Medibank (ASX:MPL) share price lifts as staff vaccine mandate hits headlines

Here's the latest news from Medibank Private.

| More on:
man receiving covid 19 vaccine moderna biontech

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is in the green today amid news the company will soon require nearly all its staff to be vaccinated against COVID-19.

Previously, only Medibank's front-line employees had to be vaccinated against COVID-19.

Medibank released the potentially divisive announcement yesterday and many media outlets reported on the changes after the ASX closed.

At the time of writing, the Medibank share price is $3.55, 0.85% higher than its previous close.

That's relatively in line with the broader market's performance this morning. Right now, the S&P/ASX 200 Index (ASX: XJO) has gained 0.2%. Meanwhile, the All Ordinaries Index (ASX: XAO) is up 0.3%.

Let's take a closer look at the latest news from Medibank.

Medibank extends employee vaccine mandate

The Medibank share price is gaining today amid headlines most of its staff are facing vaccination deadlines.

It follows fellow ASX-listed companies Crown Resorts Ltd (ASX: CWN) and Qantas Airways Limited's (ASX: QAN) decisions to do the same. Qantas declared all its staff must have a COVID-19 vaccination in August, while Crown mandated vaccination for employees last month.

Employees working in Medibank's retail or offices will soon need to be at least partially inoculated against COVID-19 to attend their workplaces or work events.

Those working in Medibank's retail segment must have had 2 doses of a COVID-19 vaccine by 15 December. All other employees face a deadline of 31 January 2022.  

Additionally, its executive leadership team and board of directors will be fully inoculated against COVID-19 by mid-October.

Employees who work completely from home are exempt from the mandate, as are those who can't get vaccinated for medical reasons.

Previously, Medibank required its frontline health workers to have at least one jab by 1 November, while those working in residential aged care had to have had their first dose by mid-September.

Commentary from management

Medibank's CEO David Koczka commented on the company's new vaccine mandate, saying:

As a company with more than 1,400 health professionals and a broader team focused on health and wellbeing each day, there is widespread understanding of the benefits of COVID vaccination across our business…

We've made this decision to help keep our people and customers safe and to support the immense effort of the nation's healthcare workers.

Medibank share price snapshot

The Medibank share price has been performing well on the ASX lately.

It has gained 16.6% since the start of 2021. It is also 36.8% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »